Rating History for Galectin Therapeutics (GALT) by H.C. Wainwright

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/17/2025 Matthew Keller New Coverage Buy
(N/A)
6.00
(N/A)
1.49
(2.35)
57.72% Details